tiprankstipranks
SAGE Therapeutics (SAGE)
NASDAQ:SAGE

SAGE Therapeutics (SAGE) Ownership - Who Owns SAGE Therapeutics?

860 Followers

SAGE Therapeutics (SAGE) Ownership Overview

7.91%35.35%49.26%7.49%
49.26% Other Institutional Investors
7.49% Public Companies and
Individual Investors
The ownership structure of SAGE Therapeutics (SAGE) stock is a mix of institutional, retail and individual investors. Approximately 84.60% of the company’s stock is owned by Institutional Investors, 7.91% is owned by Insiders and 7.49% is owned by Public Companies and Individual Investors.
The ownership structure of SAGE Therapeutics (SAGE) stock is a mix of institutional, retail and individual investors. Approximately 84.60% of the company’s stock is owned by Institutional Investors, 7.91% is owned by Insiders and 7.49% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Jan 04, 2024
Kimi Iguchi
Cfo & Treasurer
Bought$2233
Aug 11, 2023Bought$37260

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2024Sold$1044661
Mar 31, 2024Bought$1964532
Mar 31, 2024Bought$5153500
Mar 31, 2024Bought$7631246

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
4,818,439Institution8.01%58,062,190
4,388,284Institution7.29%52,878,822
4,304,671Institution7.15%51,871,286
3,224,371Institution5.36%38,853,671
2,620,871Institution4.35%31,581,496
2,359,132Institution3.92%28,427,541
2,124,699Insider3.53%25,602,623
1,232,649Insider2.05%14,853,420
969,906Institution1.61%11,687,367
922,252Institution1.53%11,113,137

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
4,388,284Institution7.29%52,878,822
4,304,671Institution7.15%51,871,286
2,620,871Institution4.35%31,581,496
969,906Institution1.61%11,687,367
922,252Institution1.53%11,113,137
606,168Institution1.01%7,304,324
565,475Institution0.94%6,813,974
551,871Institution0.92%6,650,046
472,445Institution0.79%5,692,962
453,869Institution0.75%5,469,121

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
3,157,118Institution5.25%36,938,281
1,550,086Institution2.58%21,608,199
1,303,847Institution2.17%18,175,627
1,229,022Institution2.04%13,740,466
786,323Institution1.31%10,961,343
734,313Institution1.22%10,236,323
416,867Institution0.69%4,660,573
349,942Institution0.58%3,912,352
247,594Institution0.41%2,896,850
199,313Institution0.33%2,778,423

FAQ

Who Owns SAGE Therapeutics (SAGE)?
According to the latest TipRanks data, approximately 49.26% of the company's stock is held by institutional investors, 7.91% is held by insiders, and 7.49% is held by retail investors.
    What percentage of SAGE Therapeutics (SAGE) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 49.26% of SAGE Therapeutics (SAGE) stock is held by institutional investors.
      What percentage of SAGE Therapeutics (SAGE) stock is held by retail investors?
      According to the latest TipRanks data, approximately 7.49% of SAGE Therapeutics (SAGE) stock is held by retail investors.
        Who owns the most shares of SAGE Therapeutics (SAGE)?
        Vanguard owns the most shares of SAGE Therapeutics (SAGE).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis